Table 4

Comparison of risk categories of Framingham general CVD risk score and medications used in a 10-year interval (1998–2007)

SexFramingham: CVD risk category in 1998 (%)Anti-HPT agentsAntilipid agentsHypoglycaemic agents
(N, %)(N, %)(N, %)
199820071998200719982007
Male (N=327)Low risk score <104 (33)8 (80)1 (8)4 (40)6 (50)5 (50)
Medium risk score 10–2029 (52)43 (78)5 (9)27 (49)19 (34)23 (43)
High risk Score >20184 (71)224 (94)19 (7)145 (60)143 (55)168 (70)
Female (N=640)Low risk score <1045 (33)85 (66)17 (13)78 (60)59 (44)57 (44)
Medium risk score 10–20120 (51)193 (85)29 (12)158 (69)112 (48)135 (59)
High risk score >20195 (73)238 (96)24 (9)196 (79)160 (60)187 (75)
  • CVD, cardiovascular disease; HPT, hypertensive.